BIOMARIN
BIOMARIN PHARMACEUTICAL INC
Quick answer
BIOMARIN is a pharma company (BMRN) headquartered in NOVATO, CA, USA with 24 tracked pipeline programs.
Pipeline (24)
Aldurazyme
Mucopolysaccharidosis I
1 trials projectBMN 110
Mucopolysaccharidosis IVA (Morquio A Syndrome)
1 trials projectBMN 110 - Weekly
Mucopolysaccharidosis IV A
1 trials projectBMN 110 Weekly
MPS IV A
1 trials projectBMN 111
Achondroplasia
6 trials projectBMN 165
Phenylketonuria
1 trials projectBMN 333
Achondroplasia
1 trials projectBMN 701
Late-onset Pompe Disease
1 trials projectBMN165 20mg/day
Phenylketonuria (PKU)
1 trials projectDrisapersen
Muscular Dystrophies
2 trials projectINZ-701
Ectonucleotide Pyrophosphatase/phosphodiesterase1 Deficiency
2 trials projectKuvan®
Autistic Disorder
1 trials projectN-acetylgalactosamine 4-sulfatase
Mucopolysaccharidosis VI
3 trials projectPegvaliase
Phenylketonuria (PKU)
2 trials projectPlacebo
Mucopolysaccharidosis VI
1 trials projectSapropterin Dihydrochloride
Phenylketonurias
3 trials projectSapropterin dihydrochloride
Phenylketonuria
4 trials projectVosoritide
Hypochondroplasia
3 trials projectrhIDU (recombinant human-Alpha-L-Iduronidase)
Mucopolysaccharidosis I
1 trials projectsapropterin
Behavioral Manifestations of Lesch-Nyhan Disease
1 trials projectsapropterin dihydrochloride, 6R-BH4, tetrahydrobiopterin
Phenylketonurias
1 trials projectvaloctocogene roxaparvovec
Hemophilia A
5 trials project6R BH4
Kidney Disease
1 trials project6R-BH4
Coronary Artery Disease
1 trialsDrugs (7)
Patents (8)
US 12427171
Krill oil composition enriched in LPC-DHA and LPC-EPA
patentUS 12331293
Bispecific antisense oligonucleotides for dystrophin exon skipping
patentUS 12239692
Adeno-associated virus factor VIII vectors
patentUS 12233106
C-type natriuretic peptide variants to treat skeletal dysplasia in children
patentUS 12214015
Use of c-type natriuretic peptide variants to treat osteoarthritis
patentUS 12194064
Process of producing concentrated therapeutic phospholipid composition from kril
patentUS 12188058
Manufacture of active highly phosphorylated human lysosomal sulfatase enzymes an
patentUS 12076333
Lysophosphatidylcholine compositions